this multicentre , double-blind , placebo controlled , between-patient study in general practice in the united kingdom examined the effect of oral n-acetylcysteine ( fabrol ) on the symptomatology of patients with chronic bronchitis over a 3-month period .
C0001047
n-acetylcysteine
C0591477
fabrol